Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NSF GMP program

This article was originally published in The Tan Sheet

Executive Summary

NSF International announces May 30 its good manufacturing practices readiness program, "One Step Ahead," which includes an online service center to help manufacturers prepare for the GMPs. NSF will audit facilities and note any non-conformances, giving firms opportunities to take corrective action before FDA audits. NSF's program offers a source book containing standard operating procedure templates and a trial self-audit tool. FDA and the Office of Management and Budget announced GMPs received final clearance from OMB on May 9 (1"The Tan Sheet" May 14, 2007, p. 5)...

You may also be interested in...



Dietary Supplement GMPs Back To FDA; Publication Expected In June

Dietary supplement good manufacturing practices have received final clearance by the Office of Management and Budget, OMB and FDA confirmed May 9

QUOTED. 28 January 2020. Steven Falowski.

Abbott is encouraged by results from two studies of its Proclaim XR neurostimulation system for chronic pain, presented at the annual North American Neuromodulation Society (NANS) meeting in Las Vegas. See what Steven Falowski of Neurosurgical Associates of Lancester in Pennsylvania said about it here.

Japan Phase III Failure To End Mono Opdivo Hopes In Ovarian Cancer?

While disappointing result will probably put an end to single-drug plans in ovarian cancer, the blockbuster anti-PD-1 immunotherapy remains in combination development for the indication.

Topics

UsernamePublicRestriction

Register

PS100578

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel